Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis
Authors:
- 19 October 2015
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 31 (12) , 917-921
Abstract
(2015). Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecological Endocrinology: Vol. 31, No. 12, pp. 917-921. doi: 10.3109/09513590.2015.1096337Keywords
This publication has 33 references indexed in Scilit:
- A historical perspective of aromatase inhibitors for ovulation inductionFertility and Sterility, 2012
- Endometrial receptivity defects during IVF cycles with and without letrozoleHuman Reproduction, 2012
- A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndromeJournal of Human Reproductive Sciences, 2012
- Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trialJournal of Human Reproductive Sciences, 2012
- Letrozole for ovulation induction and controlled ovarian hyperstimulationCurrent Opinion in Obstetrics and Gynecology, 2010
- Use of letrozole in assisted reproduction: a systematic review and meta-analysisHuman Reproduction Update, 2008
- Consensus on infertility treatment related to polycystic ovary syndromeFertility and Sterility, 2008
- The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and GonadotropinsFertility and Sterility, 2005
- Aromatase inhibitors and teratogenesisFertility and Sterility, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003